Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Haleos Labs Ltd

HALEOSLABS.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$15.55

▲ +0.64%

Market Cap $47.02M · Vol 117

Key Metrics

P/E Ratio

28.40

FWD: N/A

Market Cap

$47.02M

Micro Cap

Div Yield

0.10%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

43.36

Momentum

Beta

0.68

vs Market

52W High

$18.59

16.44% below

52W Low

$11.21

30.67% above

Volume

117

Avg 773

P/B

1.69

Price-to-book

ROE

N/A

Return on equity

Free Float

25.03%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Haleos Labs Ltd (HALEOSLABS.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does HALEOSLABS.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.85%

-6.76%

-7.86%

+14.18%

YTD

+12.11%

+37.46%

+158.07%

+94.87%

Financials & Valuation

TTM · Annual

Total Revenue	$35.72M
Net Income	$1.90M
Revenue Growth (YoY)	-11.59%
Gross Margin	33.97%
Operating Margin	8.75%
Net Profit Margin	5.33%
ROE	N/A
ROA · ROIC	5.97% · 6.85%

P/E Ratio	28.40
Forward P/E (FY1)	N/A
PEG Ratio	-1.50
P/S	1.08
P/B	1.69
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	3.02M

Technical Indicators

50-Day SMA	$15.68
200-Day SMA	$14.35
RSI (14)	43.36
Beta	0.68
52-Week High	$18.59
52-Week Low	$11.21

Volume Today	117
Avg Daily Volume (30D)	773
Relative Volume	0.15x
Volatility (10D)	47.20
Volatility (30D)	35.64
Free Float	25.03%

Analyst Consensus

N/A

Current Price $15.55

Mean Target N/A

52W Low$11.21 52W High$18.59

Current

Target

$11.21 $18.59

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG00CMLQ860

ISININE320X01016

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Haleos Labs Limited, formerly, SMS Lifesciences India Limited, is an India-based company that is engaged in the business of manufacturing of active pharma ingredients (API) and their intermediates. The Company's API products include Ranitidine Hydrochloride (Form-2) USP / Ph. Eur / IP, Famotidine USP / Ph. Eur / IP, Sildenafil Citrate USP / Ph. Eur / IP, Allopurinol USP / EP / IP, Ropivacaine Hydrochloride USP / EP / IP, Dapsone USP/ EP /BP, Sibutramine Hydrochloride USP, Itraconazole USP / Ph. Eur, Fosphenytoin Sodium USP, Domperidone / Domperidone Maleate EP / IP, Brinzolamide, Tiagabine, Fosaprepitant and Albendazole, among others. Its intermediate offerings include Ranitidine HCl Intermediates, Rizatriptan Intermediates and Imidapril Intermediates. The Company's manufacturing facilities are located at Kazipally and Jeedimetla, and its research and development center is at Sanath Nagar in Hyderabad. The Company's wholly owned subsidiary is Mahi Drugs Private Limited.